FDA Inspection 875803 — Neogen Corporation

Neogen Corporation — FEI 1120041

The FDA completed an inspection of Neogen Corporation on Apr 11, 2014 in Lansing, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 7 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 11, 2014
Fiscal Year
2014
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Lansing, MI (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
1472221 CFR 820.40Procedures not adequately established or maintained
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
319021 CFR 820.30(g)Design validation acceptance criteria
369621 CFR 820.100(b)Documentation
405921 CFR 820.22Quality Audits - defined intervals

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.